Literature DB >> 20083854

Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.

M Stanislawowski1, P M Wierzbicki, A Golab, K Adrych, D Kartanowicz, J Wypych, J Godlewski, M Smoczynski, Z Kmiec.   

Abstract

OBJECTIVE: Although there is a convincing evidence supporting an important role for microorganisms in the pathogenesis of Inflammatory Bowel Disease (IBD) which comprises ulcerative colitis (UC) and Crohn's disease (CD), the specific mechanisms involved remain unclear. Toll-like receptors (TLR) recognize various molecules of microbiota including flagellin, the principal protein of motile comensal and pathogenic bacteria implicated in the pathogenesis of IBD. AIM: To investigate the expression of the TLR-5 receptors at the mRNA and protein levels in the mucosa of UC patients.
MATERIALS AND METHODS: TLR-5 mRNA was quantified by the validated real-time PCR (QPCR) in mucosal biopsies of 99 UC patients and 34 control patients and TLR-5 protein was detected by immunohistochemistry (IHC) in 57 UC and 10 control patients.
RESULTS: Significantly decreased TLR-5 gene expression at mRNA and protein level was found in the mucosa of patients with moderate and severe disease activity as compared to patients with low UC activity and control. TLR-5 immunoreactivity was found in the mucosa of UC patients and normal controls in the cytoplasm of enterocytes and at their basolateral domain. However, the intensity of the IHC reaction in specimens from UC patients was substantially lower than in control samples.
CONCLUSION: The decreased expression of TLR-5 gene and protein in the mucosa of UC patients suggests that down-regulation of TLR-5 is probably caused by the increased number of ligand molecules in the proximity of epithelial cells in the inflamed tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083854

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  16 in total

1.  Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?

Authors:  P Fernandes; J MacSharry; T Darby; A Fanning; F Shanahan; A Houston; E Brint
Journal:  Clin Exp Immunol       Date:  2015-11-26       Impact factor: 4.330

2.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

3.  Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis.

Authors:  Nabeetha A Nagalingam; John Y Kao; Vincent B Young
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

4.  Role of Toll-Like Receptor 5 in the Development of Ulcerative Colitis.

Authors:  A Falah Alshimerry; R Ghalib Farhood; H Hasan Shakir
Journal:  Arch Razi Inst       Date:  2021-12-30

5.  Chronic HIV Infection Is Associated with Upregulation of Proinflammatory Cytokine and Chemokine and Alpha Defensin Gene Expression in Colorectal Mucosa.

Authors:  Jennifer Mait-Kaufman; Esra Fakioglu; Pedro M M Mesquita; Julie Elliott; Yungtai Lo; Rebecca Pellett Madan
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-08       Impact factor: 2.205

6.  Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs.

Authors:  Aarti Kathrani; Arthur House; Brian Catchpole; Angela Murphy; Alex German; Dirk Werling; Karin Allenspach
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

7.  Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Authors:  Fausto Sánchez-Muñoz; Gabriela Fonseca-Camarillo; Marco A Villeda-Ramírez; Elizabeth Miranda-Pérez; Edgar J Mendivil; Rafael Barreto-Zúñiga; Misael Uribe; Rafael Bojalil; Aarón Domínguez-López; Jesús K Yamamoto-Furusho
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

8.  TLR5 risk-associated haplotype for canine inflammatory bowel disease confers hyper-responsiveness to flagellin.

Authors:  Aarti Kathrani; Angela Holder; Brian Catchpole; Lorena Alvarez; Kenneth Simpson; Dirk Werling; Karin Allenspach
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

9.  The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.

Authors:  Anna Liberek; Zbigniew Kmieć; Dorota Kartanowicz; Piotr M Wierzbicki; Marcin Stanisławowski; Lucyna Kaszubowska; Grażyna Luczak; Magdalena Góra-Gębka; Piotr Landowski; Agnieszka Szlagatys-Sidorkiewicz; Tomasz Liberek; Barbara Kamińska; Joanna Jakóbkiewicz-Banecka; Grzegorz Węgrzyn
Journal:  Int J Colorectal Dis       Date:  2012-05-15       Impact factor: 2.571

10.  The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.

Authors:  Babajide A Ojo; Kelli L VanDussen; Michael J Rosen
Journal:  Inflamm Bowel Dis       Date:  2022-02-01       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.